Newsom-Davis J - Search Results

1

Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.

Johnston I, Lang B, Leys K, Newsom-Davis J. Johnston I, et al. Neurology. 1994 Feb;44(2):334-8. doi: 10.1212/wnl.44.2.334. Neurology. 1994. PMID: 8309586

2

The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.

Pinto A, Iwasa K, Newland C, Newsom-Davis J, Lang B. Pinto A, et al. Muscle Nerve. 2002 May;25(5):715-724. doi: 10.1002/mus.10087. Muscle Nerve. 2002. PMID: 11994966

3

Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.

Leys K, Lang B, Johnston I, Newsom-Davis J. Leys K, et al. Ann Neurol. 1991 Mar;29(3):307-14. doi: 10.1002/ana.410290313. Ann Neurol. 1991. PMID: 1645944

4

Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients.

Newsom-Davis J, Leys K, Vincent A, Ferguson I, Modi G, Mills K. Newsom-Davis J, et al. J Neurol Neurosurg Psychiatry. 1991 May;54(5):452-3. doi: 10.1136/jnnp.54.5.452. J Neurol Neurosurg Psychiatry. 1991. PMID: 1650816 Free PMC article.

5

Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.

Yamamoto T, Vincent A, Ciulla TA, Lang B, Johnston I, Newsom-Davis J. Yamamoto T, et al. Ann Neurol. 1991 Oct;30(4):550-7. doi: 10.1002/ana.410300407. Ann Neurol. 1991. PMID: 1665051

6

Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity.

Lang B, Vincent A, Murray NM, Newsom-Davis J. Lang B, et al. Ann Neurol. 1989 Mar;25(3):265-71. doi: 10.1002/ana.410250310. Ann Neurol. 1989. PMID: 2543262

7

Immunopathology of the Lambert-Eaton myasthenic syndrome.

Lang B, Newsom-Davis J. Lang B, et al. Springer Semin Immunopathol. 1995;17(1):3-15. doi: 10.1007/BF00194096. Springer Semin Immunopathol. 1995. PMID: 7482225 Review.

8

An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.

Motomura M, Johnston I, Lang B, Vincent A, Newsom-Davis J. Motomura M, et al. J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):85-7. doi: 10.1136/jnnp.58.1.85. J Neurol Neurosurg Psychiatry. 1995. PMID: 7823075 Free PMC article.

9

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.

Bain PG, Motomura M, Newsom-Davis J, Misbah SA, Chapel HM, Lee ML, Vincent A, Lang B. Bain PG, et al. Neurology. 1996 Sep;47(3):678-83. doi: 10.1212/wnl.47.3.678. Neurology. 1996. PMID: 8797464 Clinical Trial.

10

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.

Motomura M, Lang B, Johnston I, Palace J, Vincent A, Newsom-Davis J. Motomura M, et al. J Neurol Sci. 1997 Mar 20;147(1):35-42. doi: 10.1016/s0022-510x(96)05303-8. J Neurol Sci. 1997. PMID: 9094058

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters